Tag : March

CCT Impact

Paybotic, a Leading Provider of Affordable Payment Solutions in the Cannabis Industry and Surrounding Markets, Participating in Trade Shows Across the U.S. in March, April, and May 2022

CCT IMPACT Agent
Paybotic, a leading provider of affordable payment solutions in the cannabis industry and surrounding markets, is pleased to showcase its products and services at several key trade shows across the U.S. in March, April, and May 2022. Recognizing the growing need for its cannabis payment solution services as the industry continues......
CCT Impact

Xebra on Track to Deliver First Cannabis Harvest in The Netherlands in March

CCT IMPACT Agent
Xebra Brands Ltd. (“Xebra”) (CSE: XBRA) (OTCQB: XBRAF) (FSE: 9YC), a cannabis company, is pleased to announce that its cannabis cultivation in the Netherlands is in the flowering stage, as Xebra readies to harvest and submit samples of its crop to Dutch authorities, by the end of March. Two samples will be delivered, one......
CCT Impact

Evogene to Attend the 34th Annual ROTH Investor Conference in Dana Point California Between March 13-15, 2022

CCT IMPACT Agent
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, today announced that it will present at the 34th Annual ROTH Conference being held both virtually and in-person in Dana Point, California on March 13-15, 2022. The conference will feature on-demand......
CCT Impact

Trulieve Announces March 2022 Conference Participation

CCT IMPACT Agent
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the U.S., today announced planned participation in upcoming conferences in March. 34th Annual Roth Conference, March 14, 2022: President Steve White will participate in investor meetings. 2022 SXSW Conference, March 15, 2022: Chief Marketing Officer Valda Coryat will participate in a panel discussion “Cannabis: the......
CCT Impact

Enveric Biosciences to Participate in Upcoming Investor Conferences in March

CCT IMPACT Agent
Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, today announced that David Johnson, Chairman and Chief Executive Officer, will participate in two upcoming investor conferences in March: M Vest and Maxim Group Inaugural Emerging Growth Conference to......